News

Koya Medical to Speak at the Stifel 2025 Healthcare Conference in New York

NEW YORK, Nov. 13, 2025 /PRNewswire/ -- Koya Medical ("Koya"), an emerging medtech innovator advancing patient-centered solutions in vascular health,…

2 months ago

Suno Software Accelerates AI Innovation to Transform Hearing Clinic Operations

The fastest-growing practice-management platform for hearing clinics, Suno Software is leveraging new funding to accelerate its AI product roadmap -…

2 months ago

NVNA and Hospice Rebrands as Croí Health 

The nonprofit is changing its name to better represent their growth as they continue to expand access to patient-centered care…

2 months ago

Hemostemix Presents ACP-01 Data at University of Florida Grand Rounds: Highlights Strong Safety, Functional Gains, and Florida Access Pathway

Session led by neurosurgeon Dr. Fraser Henderson and Hemostemix CEO Thomas Smeenk for the University of Florida's Department of Surgery,…

2 months ago

 Driving Change in Correctional Healthcare: NaphCare’s Commitment to Innovation and Impact

 How an independent leader is transforming care for incarcerated individuals with cutting-edge technology and patient-first solutionsBIRMINGHAM, Ala.--(BUSINESS WIRE)--NaphCare, a nationwide…

2 months ago

Entero’s Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects announced in the last 90…

2 months ago

National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced

BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and…

2 months ago

Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)

The study demonstrated that personalizing the stimulation parameters to each user dramatically enhanced autonomic effects FREMONT, CA / ACCESS Newswire…

2 months ago

Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study

NEW YORK CITY, NY / ACCESS Newswire / November 13, 2025 / Protagenic Therapeutics Inc. (NASDAQ:PTIX), a biopharmaceutical company developing…

2 months ago